Cargando…
Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
Growing evidence suggests the Δ133p53α isoform may function as an oncogene. It is overexpressed in many tumors, stimulates pathways involved in tumor progression, and inhibits some activities of wild-type p53, including transactivation and apoptosis. We hypothesized that Δ133p53α would have an even...
Autores principales: | Slatter, T L, Hung, N, Bowie, S, Campbell, H, Rubio, C, Speidel, D, Wilson, M, Baird, M, Royds, J A, Braithwaite, A W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669831/ https://www.ncbi.nlm.nih.gov/pubmed/26068791 http://dx.doi.org/10.1038/cddis.2015.149 |
Ejemplares similares
-
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
por: Kazantseva, Marina, et al.
Publicado: (2018) -
Δ113p53/Δ133p53: survival and integrity
por: Chen, Jun, et al.
Publicado: (2015) -
Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis
por: Jesus, Alexandra N. Boix De, et al.
Publicado: (2023) -
The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020) -
The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer
por: Kazantseva, Marina, et al.
Publicado: (2019)